ADVANCED TECHNOLOGY for laparoscopic, endolumenal, endoscopic and robotic surgeries
The compact and pedal activated EVA15 smoke evacuation and insufflation system safely filters hazardous contaminants of surgical smoke before they become airborne in the OR. The EVA15 0.1 micron two-stage charcoal filter enables hospitals to follow 2017 AORN Guideline for surgical smoke safety. EVA15 conveniently connects to OR scavenging systems.
The compact and pedal activated EVA15 smoke evacuation and insufflation system safely filters hazardous contaminants of surgical smoke before they become airborne in the OR. The EVA15 0.1 micron two-stage charcoal filter enables hospitals to follow 2017 AORN Guideline for surgical smoke safety. EVA15 conveniently connects to OR scavenging systems.
Location: Ireland, Galway
Employees: 11-50
Total raised: $8M
Founded date: 2018
Investors 1
| Date | Name | Website |
| 30.06.2021 | Seroba Lif... | seroba-lif... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 28.06.2021 | Series A | $8M | Seroba Lif... |
Mentions in press and media 6
| Date | Title | Description |
| 30.07.2023 | Palliare announces EU CE mark approval under new Medical Devices Regulation. | Galway, Ireland and Oceanside, CA, USA. 28 July, 2023. Seroba’s portfolio company, Palliare, a leading developer of advanced insufflation technologies, has received EU CE Mark certification under the new EU Medical Devices Regulation (MDR) ... |
| 01.02.2023 | U.S. FDA Grants 510(k) Expanded Indication for Palliare’s EVA15 Insufflation Technology to Accommodate Higher Pressure Range. | 31 January 2023. Galway, Ireland and Oceanside, California, USA. Palliare, a leading developer of advanced insufflation technologies, has received an expanded 510(k) indication from the U.S. Food and Drug Administration for its EVA15 Insuff... |
| 28.06.2021 | Palliare Closes $8M Series A Funding Round | Palliare, a Galway, Ireland-based safe operating room company, closed an $8m Series A funding round. The round was led by Seroba Life Sciences, with participation from SCM AD Ventures, Western Development Commission, and several private inv... |
| 28.06.2021 | Palliare : Completes $8m Series A Funding Round | Palliare, an emerging company with the vision to create a safer operating room, today announced the closing of an oversubscribed $8 million Series A funding round. The round was led by leading European Life Sciences Venture Capital firm Ser... |
| - | Seroba Leads $8M Series A Investment into Palliare | Galway, Ireland. 28 June 2021. Palliare, an emerging company with the vision to create a safer operating room, has announced the closing of an oversubscribed $8 million Series A funding round. The round was led by leading European Life Sci... |
| - | Palliare announces US FDA 510(k) clearance to extend the indications of its EVA15 insufflation technology for use in endoscopic surgery. | Galway, Ireland. 15 July 2021. Seroba portfolio company, Palliare, an emerging company with the vision to create a safer operating room, has announced that it has received FDA 510(k) clearance for its END-200 tubeset, which extends the capa... |